Short-term stake in PureTech Health plc (OTCMKTS:PTCHF) decreases by 66.7%


PureTech Health plc (OTCMKTS: PTCHFGet a rating) was the target of a significant drop in short rates during the month of May. As of May 31, there was short interest totaling 100 shares, down 66.7% from May 15’s total of 300 shares. Based on an average trading volume of 2,300 shares, the short-term interest rate ratio is currently 0.0 day.

Shares of PTCHF traded down $0.17 during Friday’s midday session, hitting $2.21. 47,480 shares of the company were traded, against an average volume of 7,389. The company’s 50-day simple moving average is $2.34 and its 200-day simple moving average is $3.07. PureTech Health has a 52 week low of $1.97 and a 52 week high of $5.33.

Company Profile PureTech Health (Get a rating)

PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops and markets drugs for inflammatory, fibrotic and immunological, incurable, lymphatic and gastrointestinal, neurological and neuropsychological cancers, and other diseases in the United States. The Company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer’s disease; a regenerative biology platform for androgenetic alopecia, epithelial aging and other medical conditions; an immunomodulation platform to treat chronic and acute inflammatory disorders; oral therapies based on defined consortia of bacteria are isolated from the human microbiome; and therapies to treat cognitive dysfunctions associated with depression, multiple sclerosis, post-COVID and critical care, and cancer-related conditions.

See also



Get news and reviews for PureTech Health Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for PureTech Health and related companies with MarketBeat.com’s free daily email newsletter.

Comments are closed.